HPV vaccine impact in Australian women: ready for an HPV-based screening program

Med J Aust. 2016 Mar 21;204(5):184-184e1. doi: 10.5694/mja15.01038.

Authors

Julia Ml Brotherton¹, Dorota M Gertig², Cathryn May², Genevieve Chappell², Marion Saville²

Affiliations

¹ Victorian Cytology Service, Melbourne, VIC jbrother@vcs.org.au.
² Victorian Cytology Service, Melbourne, VIC.

PMID: 26985843
DOI: 10.5694/mja15.01038

No abstract available

MeSH terms

Adolescent
Adult
Child
Cross-Sectional Studies
Female
Human Papillomavirus DNA Tests*
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 / administration & dosage*
Humans
Mass Screening*
Precancerous Conditions / epidemiology
Precancerous Conditions / prevention & control
Treatment Outcome
Uterine Cervical Neoplasms / epidemiology
Uterine Cervical Neoplasms / prevention & control
Vaginal Smears*
Victoria
Young Adult

Substances

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18